Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

Table 4 Acceptance rate of actions for four pharmacotherapeutic categories performed by electronic notes^e

Category	Total number of patients (n)	Exclusion		Total number of actions (n)	Number of actions accepted by physician (n (%))
Category	Total number of patients (n)	Duplicates	Not possible to verify*	Total number of actions (n)	Number of actions accepted by physician (n (%))
Drug use in renal insufficiency	61	10	6	45	31 (69%)
Drugs with high potential of QTc prolongation	78	4	11	63	34 (54%)
Drugs with restricted indication or dosing	51	3	5	43	21 (49%)
Overruled very severe DDIs	110	25	7	78	43 (55%)
Total	300	71		229	129 (56%)

^eDDI drug-drug interaction, n absolute number. *notes for which the acceptance rate could not be verified because of a discharge or transfer to another hospital unit

ISSN: 1472-6947